Cosmos Health Inc. (NASDAQ:COSM) reported Q2 revenues of $12.36 million, down 6.4% Y/Y. 

The company reported adjusted EPS of $0.01, compared to a $(0.35) loss in the prior year. 

Gross profit slumped 48.7% Y/Y to $0.95 million.

Revenues were affected, in part, due to unfavorable USD to EUR and GBP exchange rate movements.

Adjusted EBITDA in the quarter under review was $0.23 million, lower than $0.299 million a year ago.

Net loss in the quarter narrowed on year to $(0.98) million from $(1.24) million loss a year ago.

Interest expense in Q2 lowered to $0.24 million from $0.62 million a year ago.

Price Action: COSM shares are trading higher by 3.7% to $1.39 on the last check Tuesday.